• 
• 
• 
• 

FDA News and Drug Updates

FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer

Inrebic Receives FDA Approval for Adults with Myelofibrosis

FDA Approved Erleada for Metastatic Castration-Sensitive Prostate Cancer

Supportive Care

What an Aging Population Means for Cancer Treatment

Saima Iqbal, Ishmam Khan

Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting

Meg Barbor, MPH

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

View All Supportive Care Articles

Lung Cancer

Long-Term Data Confirm Survival Benefit for Pembrolizumab in Advanced NSCLC

Phoebe Starr

November 25, 2019 – Oncology News & Updates

Repotrectinib, an Investigational TKI, Induces Response in ROS1-Fusion–Positive NSCLC

Wayne Kuznar

View All Lung Cancer Articles

Conference Correspondent

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

The Importance of Compassion: Perspective From a Lifelong Patient

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer

Addressing the Second Victim Phenomenon

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

View All Conference Correspondent Articles

Most Popular Articles

November 18, 2019 — Oncology News & Updates

Web Exclusives - Drug Updates, FDA Updates, Hepatocellular Carcinoma, In the News, Lymphoma

October 28, 2019 – Oncology News & Updates

Web Exclusives - FDA Updates, In the News, Ovarian Cancer

November 11, 2019 — Oncology News & Updates

Web Exclusives - FDA Updates, In the News

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

Web Exclusives - FDA Updates